Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site
- PMID: 1648738
- PMCID: PMC52079
- DOI: 10.1073/pnas.88.14.6343
Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site
Abstract
Epstein-Barr virus (EBV) expresses six nuclear antigens (EBNAs) and three integral latent membrane proteins (LMPs) in latently infected growth-transformed B lymphoblastoid cell lines (LCLs). In contrast, EBV protein expression in Burkitt lymphoma tissue or in newly established Burkitt lymphoma cell lines is frequently restricted to the EBV genome maintenance protein, EBNA-1. EBNA-1 expression in the absence of other EBNAs and LMP-1 has been an enigma since, in LCLs, all EBNA mRNAs are processed from a single transcript. We now show that the basis for restricted EBV expression in Burkitt lymphoma cells is selective EBNA-1 mRNA transcription from a hitherto unrecognized promoter that is 50 kb closer to the EBNA-1-encoding exon than previously described EBNA-1 promoters. Infected cells with EBNA-1-restricted expression could preferentially persist in vivo in the face of EBV-immune T-cell responses, which are frequently directed against other EBNAs and are also dependent on LMP-1 expression.
Similar articles
-
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4. doi: 10.1073/pnas.88.15.6550. Proc Natl Acad Sci U S A. 1991. PMID: 1713681 Free PMC article.
-
Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.Blood. 1992 Jul 15;80(2):459-69. Blood. 1992. PMID: 1378321
-
Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.Int J Cancer. 1993 Feb 20;53(4):621-7. doi: 10.1002/ijc.2910530416. Int J Cancer. 1993. PMID: 8382194
-
T cell recognition of Epstein-Barr virus associated lymphomas.Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review.
-
Immortalizing genes of Epstein-Barr virus.Adv Virus Res. 1991;40:19-55. doi: 10.1016/s0065-3527(08)60276-6. Adv Virus Res. 1991. PMID: 1659776 Review.
Cited by
-
Molecular basis for Epstein-Barr virus induced pathogenesis and disease.Springer Semin Immunopathol. 1991;13(2):133-46. doi: 10.1007/BF00201464. Springer Semin Immunopathol. 1991. PMID: 1664982 Review. No abstract available.
-
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.J Virol. 1994 Nov;68(11):7374-85. doi: 10.1128/JVI.68.11.7374-7385.1994. J Virol. 1994. PMID: 7933121 Free PMC article.
-
Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.Mol Cell Biol. 1994 Nov;14(11):7144-52. doi: 10.1128/mcb.14.11.7144-7152.1994. Mol Cell Biol. 1994. PMID: 7935429 Free PMC article.
-
Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.J Virol. 1996 Jan;70(1):623-7. doi: 10.1128/JVI.70.1.623-627.1996. J Virol. 1996. PMID: 8523583 Free PMC article.
-
Molecular genetic analysis of Epstein-Barr virus Cp promoter function.J Virol. 1996 Mar;70(3):1695-705. doi: 10.1128/JVI.70.3.1695-1705.1996. J Virol. 1996. PMID: 8627690 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous